Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ZYDUS LIFESCIENCES ABBOTT INDIA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 49.1 20.6 238.2% View Chart
P/BV x 15.6 2.4 636.6% View Chart
Dividend Yield % 1.3 0.6 222.2%  

Financials

 ABBOTT INDIA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-22
ZYDUS LIFESCIENCES
Mar-22
ABBOTT INDIA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs23,902674 3,547.9%   
Low Rs14,553331 4,396.6%   
Sales per share (Unadj.) Rs2,315.0149.1 1,552.5%  
Earnings per share (Unadj.) Rs375.922.7 1,654.0%  
Cash flow per share (Unadj.) Rs407.029.7 1,370.8%  
Dividends per share (Unadj.) Rs275.002.50 11,000.0%  
Avg Dividend yield %1.40.5 287.4%  
Book value per share (Unadj.) Rs1,306.2166.1 786.6%  
Shares outstanding (eoy) m21.251,023.74 2.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.33.4 246.5%   
Avg P/E ratio x51.222.1 231.4%  
P/CF ratio (eoy) x47.216.9 279.2%  
Price / Book Value ratio x14.73.0 486.6%  
Dividend payout %73.211.0 665.0%   
Avg Mkt Cap Rs m408,573514,277 79.4%   
No. of employees `000NANA-   
Total wages/salary Rs m5,79521,777 26.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m49,193152,652 32.2%  
Other income Rs m7742,354 32.9%   
Total revenues Rs m49,967155,006 32.2%   
Gross profit Rs m10,87534,427 31.6%  
Depreciation Rs m6617,130 9.3%   
Interest Rs m1911,270 15.0%   
Profit before tax Rs m10,79728,381 38.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,8105,117 54.9%   
Profit after tax Rs m7,98723,264 34.3%  
Gross profit margin %22.122.6 98.0%  
Effective tax rate %26.018.0 144.4%   
Net profit margin %16.215.2 106.5%  
BALANCE SHEET DATA
Current assets Rs m38,530122,614 31.4%   
Current liabilities Rs m12,03278,394 15.3%   
Net working cap to sales %53.929.0 186.0%  
Current ratio x3.21.6 204.7%  
Inventory Days Days693 6.6%  
Debtors Days Days280 2.7%  
Net fixed assets Rs m3,541144,382 2.5%   
Share capital Rs m2131,024 20.8%   
"Free" reserves Rs m27,544168,972 16.3%   
Net worth Rs m27,756169,996 16.3%   
Long term debt Rs m03,621 0.0%   
Total assets Rs m42,072266,996 15.8%  
Interest coverage x57.523.3 246.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.6 204.5%   
Return on assets %19.49.2 211.5%  
Return on equity %28.813.7 210.3%  
Return on capital %39.617.1 231.8%  
Exports to sales %0.70-   
Imports to sales %10.214.3 71.4%   
Exports (fob) Rs m350NA-   
Imports (cif) Rs m5,03421,869 23.0%   
Fx inflow Rs m41563,065 0.7%   
Fx outflow Rs m5,11721,869 23.4%   
Net fx Rs m-4,70241,196 -11.4%   
CASH FLOW
From Operations Rs m9,47721,041 45.0%  
From Investments Rs m-3,95811,544 -34.3%  
From Financial Activity Rs m-6,374-8,683 73.4%  
Net Cashflow Rs m-85623,729 -3.6%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.1 15.5 51.8%  
FIIs % 0.2 2.6 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   83,526 408,231 20.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Abbott India vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Cadila Healthcare Share Price Performance

Period Abbott India Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.81% 1.49% -0.89%
1-Month 6.06% -8.17% -1.85%
1-Year 7.50% -10.96% -6.83%
3-Year CAGR 16.90% 16.63% 20.56%
5-Year CAGR 29.35% -0.30% 10.73%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 275.0 per share. This amounted to a Dividend Payout ratio of 73.2%.

Cadila Healthcare paid Rs 2.5, and its dividend payout ratio stood at 11.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.